International Journal of Cancer Management

Published by: Kowsar

No Association Between Expression of RAS Guanyl Releasing Protein 3 (RASGRP3) in Breast Cancer and Clinicopathological Data

Roshanak Shams 1 and Soudeh Ghafouri-Fard 1 , *
Authors Information
1 Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • International Journal of Cancer Management: September 2018, 11 (9); e69551
  • Published Online: September 4, 2018
  • Article Type: Letter
  • Received: April 18, 2018
  • Revised: April 24, 2018
  • Accepted: May 1, 2018
  • DOI: 10.5812/ijcm.69551

To Cite: Shams R, Ghafouri-Fard S. No Association Between Expression of RAS Guanyl Releasing Protein 3 (RASGRP3) in Breast Cancer and Clinicopathological Data, Int J Cancer Manag. 2018 ; 11(9):e69551. doi: 10.5812/ijcm.69551.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Acknowledgements
Footnotes
References
  • 1. Nagy Z, Kovacs I, Torok M, Toth D, Vereb G, Buzas K, et al. Function of RasGRP3 in the formation and progression of human breast cancer. Mol Cancer. 2014;13:96. doi: 10.1186/1476-4598-13-96. [PubMed: 24779681]. [PubMed Central: PMC4113147].
  • 2. Gerson KD, Maddula VS, Seligmann BE, Shearstone JR, Khan A, Mercurio AM. Effects of beta4 integrin expression on microRNA patterns in breast cancer. Biol Open. 2012;1(7):658-66. doi: 10.1242/bio.20121628. [PubMed: 23213459]. [PubMed Central: PMC3507297].
  • 3. Shamsi R, Seifi-Alan M, Behmanesh A, Omrani MD, Mirfakhraie R, Ghafouri-Fard S. A bioinformatics approach for identification of miR-100 targets implicated in breast cancer. Cell Mol Biol (Noisy-le-grand). 2017;63(10):99-105. doi: 10.14715/cmb/2017.63.10.16. [PubMed: 29096749].
  • 4. Barrett T, Edgar R. Gene expression omnibus: microarray data storage, submission, retrieval, and analysis. Methods Enzymol. 2006;411:352-69. doi: 10.1016/S0076-6879(06)11019-8. [PubMed: 16939800]. [PubMed Central: PMC1619900].
  • 5. Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98-W102. doi: 10.1093/nar/gkx247. [PubMed: 28407145]. [PubMed Central: PMC5570223].
  • 6. Yang D, Kedei N, Li L, Tao J, Velasquez JF, Michalowski AM, et al. RasGRP3 contributes to formation and maintenance of the prostate cancer phenotype. Cancer Res. 2010;70(20):7905-17. doi: 10.1158/0008-5472.CAN-09-4729. [PubMed: 20876802]. [PubMed Central: PMC2955810].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments